UBS
-
Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m). -
Chinese ride-hailing giant Didi has raised $4.4bn from its New York Stock Exchange IPO, increasing the size of the float after investors pumped more than $40bn of orders into the book.
-
The Republic of the Philippines focused on investors keen to buy long-dated bonds by selling a dual tranche dollar deal this week. The $3bn trade featured a chunky $2.25bn 25 year portion that easily trumped the sovereign's last similar outing.
-
Logan Group Co used the last of its offshore debt issuance quota to price a $300m green bond on Monday.
-
Speculative grade Italian lender Illimity is getting ready to issue its first tier two bond, having mandated leads on Monday to arrange a sub-benchmark subordinated deal.
-
SCE Intelligent Commercial Management has raised HK$1.85bn ($238.3m) after pricing its IPO at the bottom of the guidance range.
-
Shui On Land became the first Chinese corporate borrower to sell a sustainability-linked bond (SLB) this week — a move that worked to its advantage.
-
Chinese ride-hailing firm Didi Chuxing has launched its New York Stock Exchange IPO, aiming to raise $4.03bn from the largest China-into-US listing since Alibaba Group Holding’s jumbo $25bn deal in 2014.
-
Investors pumped more than $8bn in orders for Shenzhen Expressway Co's $300m capped bond on Thursday, with the Chinese issuer benefitting from its rarity value in the debt market and the stability of its business.
-
A smattering of smaller euro issuers made the most of an attractive window this week, as they looked to use the stable conditions to take “some risk off the table” ahead of the summer break.
-
-
Gazprom ended a three year absence from the Swiss franc market this week by attracting a large amount of retail participation in a Sfr600m ($653.4m) deal that launched at an attractive spread.
